Home > Clinical Trials

Saved trials

Completed
NCT00996281
Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
837 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT01430091
A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet
18 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Sickle Cell Disease
Completed
NCT01107912
Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease
155 Enrollment(s)
7 Study location(s)
Interventional (Phase I)
Coronary Artery Disease
Completed
NCT01336348
Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
100 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
ST Segment Elevation Myocardial Infarction
Completed
NCT01012336
Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin
89 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Chemotherapy-Induced Nausea and Vomiting
Ovarian Cancer
Completed
NCT01591317
Study of Prasugrel in Korean Healthy Male Volunteers
30 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Healthy Volunteers
Completed
NCT01135667
Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
106 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Percutaneous Coronary Intervention
Acute Coronary Syndromes
Unknown status
NCT01536691
Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone
338 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Cancer
Malignancy